BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15308292)

  • 1. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells.
    Yu S; Zuo X; Li Y; Zhang C; Zhou M; Zhang YA; Uéda K; Chan P
    Neurosci Lett; 2004 Aug; 367(1):34-9. PubMed ID: 15308292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein functions as a negative regulator for expression of tyrosine hydroxylase.
    Li YH; Gao N; Ye YW; Li X; Yu S; Yang H; Uéda K; Chan P
    Acta Neurol Belg; 2011 Jun; 111(2):130-5. PubMed ID: 21748932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells.
    Shavali S; Carlson EC; Swinscoe JC; Ebadi M
    J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
    Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
    Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference of alpha-synuclein with cAMP/PKA-dependent CREB signaling for tyrosine hydroxylase gene expression in SK-N-BE(2)C cells.
    Kim SS; Moon KR; Choi HJ
    Arch Pharm Res; 2011 May; 34(5):837-45. PubMed ID: 21656370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine-related and caspase-independent apoptosis in dopaminergic neurons induced by overexpression of human wild type or mutant alpha-synuclein.
    Zhou ZD; Yap BP; Gung AY; Leong SM; Ang ST; Lim TM
    Exp Cell Res; 2006 Jan; 312(2):156-70. PubMed ID: 16297908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
    Park SS; Lee D
    Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.
    Fornai F; Lenzi P; Ferrucci M; Lazzeri G; di Poggio AB; Natale G; Busceti CL; Biagioni F; Giusiani M; Ruggieri S; Paparelli A
    Brain Res Bull; 2005 May; 65(5):405-13. PubMed ID: 15833595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
    Park SS; Schulz EM; Lee D
    Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
    Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S
    Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of tyrosine hydroxylase expression and activity by Trypanosoma cruzi parasite-derived neurotrophic factor.
    Chuenkova MV; Pereiraperrin M
    Brain Res; 2006 Jul; 1099(1):167-75. PubMed ID: 16806115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synuclein.
    Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
    J Neurochem; 2006 Feb; 96(4):950-9. PubMed ID: 16412098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue.
    Zhu MY; Wang WP; Baldessarini RJ; Kim KS
    Brain Res Mol Brain Res; 2005 Feb; 133(2):167-75. PubMed ID: 15710233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system.
    Uz T; Arslan AD; Kurtuncu M; Imbesi M; Akhisaroglu M; Dwivedi Y; Pandey GN; Manev H
    Brain Res Mol Brain Res; 2005 May; 136(1-2):45-53. PubMed ID: 15893586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal PAS domain protein 1 regulates tyrosine hydroxylase level in dopaminergic neurons.
    Teh CH; Loh CC; Lam KK; Loo JM; Yan T; Lim TM
    J Neurosci Res; 2007 Jun; 85(8):1762-73. PubMed ID: 17457889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short chain fatty acids induce TH gene expression via ERK-dependent phosphorylation of CREB protein.
    Shah P; Nankova BB; Parab S; La Gamma EF
    Brain Res; 2006 Aug; 1107(1):13-23. PubMed ID: 16854387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells.
    Wu B; Liu Q; Duan C; Li Y; Yu S; Chan P; Uéda K; Yang H
    Acta Histochem; 2011 Jan; 113(1):32-5. PubMed ID: 19683335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
    Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
    J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.